Chronos Archive seal
The Human Record

Rachel Carson

Case HR-ML041-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
May 27, 1907 – April 14, 1964
Synthetic DOB
1907-05-27
Index visit
1960-03-09 at age 52
Synthetic MRN
HR-ML041-SYN-TD

Teaching objective: Evaluate a new breast lump in a postmenopausal woman of 52 with diagnostic mammography, ultrasound, and core biopsy with ER, PR, HER2, and Ki-67; above all, tell her the diagnosis directly and in plain words, at the pace she chooses, and make every treatment decision with her. Plan breast-conserving surgery or mastectomy by her informed choice, with sentinel node biopsy and germline testing; manage one to two positive sentinel nodes without axillary dissection; choose adjuvant radiation, letrozole, ribociclib, and zoledronic acid with her, and monitor the ECG, blood counts, liver tests, and electrolytes that ribociclib requires; protect bone health and her work as a writer. The teaching note contrasts this with the documented 1894 nondisclosure, when her surgeon told her that her tumor was not cancer, the usual practice of that time.

Historical timeline

DateEventClaims
May 27, 1907Born in Springdale, Pennsylvania.CLM-0001
1936Hired by the Bureau of Fisheries as a junior aquatic biologist.CLM-0002
1950Benign tumor removed from her left breast.CLM-0004
1952Resigned from the Fish and Wildlife Service to write full time.CLM-0002
Early 1960Found two lumps in her left breast while writing Silent Spring.CLM-0006
April 1960Radical mastectomy of the left breast; her surgeon did not tell her the tumor was malignant.CLM-0007, CLM-0008, CLM-0014
Late 1960Learned that the cancer had spread; radiation treatment began; worked on through other illnesses and kept the cancer private.CLM-0009, CLM-0005, CLM-0011
September 27, 1962Silent Spring published.CLM-0003
Early 1963Wrote to her cancer surgeon about angina, diseased nodes above the collarbone treated with radiation, and a shoulder bone lesion.CLM-0010
June 4, 1963Testified before a Senate subcommittee on pesticides.CLM-0012
April 14, 1964Died at home in Silver Spring, Maryland.CLM-0013

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Rachel Louise Carson was born on May 27, 1907, on a family farm in Springdale, Pennsylvania. confirmed Rachel Carson supports
About Rachel Carson supports
Rachel Carson (scientific biography) supports
D Carson was hired by the U.S. Bureau of Fisheries in 1936 as a junior aquatic biologist and rose to be editor-in-chief of the publications of its successor, the U.S. Fish and Wildlife Service. She resigned in 1952 to write full time. confirmed Rachel Carson (scientific biography) supports
About Rachel Carson supports
Rachel Carson supports
D Carson was a marine biologist and writer. Her books included Under the Sea Wind (1941) and the best-selling The Sea Around Us. Silent Spring, published on September 27, 1962, warned of the harm done by the widespread use of chemical pesticides. confirmed About Rachel Carson supports
Rachel Carson (scientific biography) supports
Griswold E. How 'Silent Spring' Ignited the Environmental Movement. New York Times Magazine, September 21, 2012 (reprint) supports
D In 1950, while preparing her second book, Carson had her first breast operation, to remove a benign tumor from her left breast.
A single secondary source gives this date; the same source dates a later operation to 1959, which other sources place in 1960. The 1950 operation is recorded as probable.
probable McCauley M. Rachel Carson, Author of Silent Spring supports
D While writing Silent Spring Carson worked through what she called "a catalogue of illnesses": flu, a sinus infection, heart trouble, arthritis, and an ulcer. She told her publisher that her disability was arthritis, and only a few friends knew the truth.
The cited sources do not date each illness. A review of the standard biography says she described her disability as arthritis to keep the cancer hidden, so the word may not describe a joint disease.
confirmed Carson, Rachel (1907–1964). Women in World History: A Biographical Encyclopedia supports
Stevens A. Review of Rachel Carson: Witness for Nature, by Linda Lear supports
D In early 1960, while writing Silent Spring, Carson found two lumps in her left breast.
The documented presentation that anchors the synthetic episode.
confirmed Call for a Cure supports
Rachel Carson (scientific biography) supports
D In April 1960 Carson had a radical mastectomy for tumors of her left breast.
Later than the synthetic index visit; linked only to the later timeline event and to the diagnosis made at the second visit.
confirmed Rachel Carson (scientific biography) supports
Carson, Rachel (1907–1964). Women in World History: A Biographical Encyclopedia supports
Griswold E. How 'Silent Spring' Ignited the Environmental Movement. New York Times Magazine, September 21, 2012 (reprint) supports
D Carson's surgeon did not tell her she had cancer, even after the radical mastectomy and when later swelling showed that the cancer had spread; when she asked direct questions he told her she had "a condition bordering on malignancy." A review of her standard biography calls this a lie on the part of the surgeon, never forgiven by the patient.
The documented nondisclosure that the synthetic episode is built to contrast. The surgeon is not named in this record.
confirmed Call for a Cure supports
Stevens A. Review of Rachel Carson: Witness for Nature, by Linda Lear supports
Burstein HJ. Fifty years of systemic therapy for breast cancer: from one size fits all to tailored therapy. Am Soc Clin Oncol Educ Book 2014:e1-3. PMID 24857085 context
D Within months of the operation the cancer had spread to her ribs and she began radiation treatment. Her biographer writes that Carson had to fight the medical profession to tell her the truth about her own illness; she later wrote to George Crile Jr. of the Cleveland Clinic, her cancer surgeon and friend, asking for his honest view of her prognosis.
How and from whom she first learned the diagnosis is not stated in the sources read; the record says only that she learned it later and sought the truth from another physician.
confirmed Rachel Carson (scientific biography) supports
Lear L, ed. Letter to Dr. George Crile, Jr., with the editor's headnote. In: Lost Woods: The Discovered Writing of Rachel Carson (Beacon Press, 1998) supports
Griswold E. How 'Silent Spring' Ignited the Environmental Movement. New York Times Magazine, September 21, 2012 (reprint) context
D Early in 1963 Carson wrote that a cardiologist had diagnosed angina, that hard, tender lymph nodes above her left collarbone had been found to be diseased and were being treated with radiation, and that an X-ray showed erosion of a bone of her left shoulder. Her cancer spread to lymph nodes, bones, and liver, with more radiation and hormone treatment.
Later than the synthetic episode and not used in it.
confirmed Lear L, ed. Letter to Dr. George Crile, Jr., with the editor's headnote. In: Lost Woods: The Discovered Writing of Rachel Carson (Beacon Press, 1998) supports
Stevens A. Review of Rachel Carson: Witness for Nature, by Linda Lear supports
D Carson kept her cancer hidden from all but a handful of friends, in part so that her illness could not be used against Silent Spring.
Her privacy is respected in the synthetic episode, which shares her diagnosis only with the people she chooses.
confirmed Lear L, ed. Letter to Dr. George Crile, Jr., with the editor's headnote. In: Lost Woods: The Discovered Writing of Rachel Carson (Beacon Press, 1998) supports
Carson, Rachel (1907–1964). Women in World History: A Biographical Encyclopedia supports
Griswold E. How 'Silent Spring' Ignited the Environmental Movement. New York Times Magazine, September 21, 2012 (reprint) supports
D On June 4, 1963, Carson testified before the Senate Government Operations Subcommittee on Reorganization and International Organizations on the control of pesticides and other chemical poisons, and she also testified before the Senate Commerce Committee. She was dying of breast cancer; her pelvis was so riddled with fractures that she could barely walk to her seat, and she wore a wig to hide hair loss.
Later than the synthetic episode and not used in it.
confirmed Rachel Carson's Statement before Congress, 1963 supports
Griswold E. How 'Silent Spring' Ignited the Environmental Movement. New York Times Magazine, September 21, 2012 (reprint) supports
Rachel Carson supports
Rachel Carson (scientific biography) supports
D Carson died of cancer at her home in Silver Spring, Maryland, on April 14, 1964, at 56.
Record the death as a fact without detail.
confirmed Rachel Carson supports
About Rachel Carson supports
Carson, Rachel (1907–1964). Women in World History: A Biographical Encyclopedia supports
Rachel Carson (1907–1964). Maryland Women's Hall of Fame supports
D In a 1961 survey of physicians, 90 percent preferred not to tell a cancer patient the diagnosis; when the same questionnaire was given in 1977, 97 percent preferred to tell.
Context for the teaching contrast: the nondisclosure Carson met was the usual practice of her time.
confirmed Oken D. What to tell cancer patients. A study of medical attitudes. JAMA 1961;175:1120-8. PMID 13730593 supports
Novack DH, et al. Changes in physicians' attitudes toward telling the cancer patient. JAMA 1979;241(9):897-900. PMID 762865 supports
Call for a Cure supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Invasive ductal carcinoma of the left breast, upper outer quadrant at 2 o'clock, 2.4 cm on imaging; core biopsy grade 2, estrogen and progesterone receptor positive, HER2 negative, Ki-67 22 percent; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern counterpart of the documented 1894 breast cancer, which was not disclosed to her active confirmed both_with_link CLM-0006, CLM-0007, CLM-0008
S Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 80 percent) active confirmed active
S New firm lump in the upper outer quadrant of the left breast, found two weeks ago; clinically suspicious; diagnostic imaging and biopsy booked resolved confirmed active CLM-0006
S Duodenal ulcer found at endoscopy seven weeks ago, with Helicobacter pylori on biopsy; treated with 14 days of bismuth quadruple therapy and completing eight weeks of omeprazole; test of cure planned resolved confirmed active
S Primary osteoarthritis of both knees, mild, with stiffness after long walks on the shore active confirmed active
S Metastatic carcinoma in two of three left axillary sentinel lymph nodes (macrometastases, no extranodal extension); pathologic stage pT2 pN1a(sn) M0, anatomic stage IIB; recurrence score 17 active confirmed active
S Long-term use of letrozole as adjuvant endocrine therapy, with ribociclib for three years active confirmed active
S Low bone mass (osteopenia) on baseline DXA before letrozole: lumbar spine T-score -1.8, femoral neck -1.3; 10-year major osteoporotic fracture risk about 7 percent (FRAX); vitamin D insufficiency active confirmed active
S Acute viral rhinosinusitis for five days while on ribociclib, with expected grade 2 neutropenia (absolute neutrophil count 1.2) and no fever; resolved with saline irrigation resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1960-03-09 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1960-03-09 Hemoglobin [Mass/volume] in Blood 12.3 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1960-03-09 Leukocytes [#/volume] in Blood by Automated count 6.4 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1960-03-09 Platelets [#/volume] in Blood by Automated count 262 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1960-03-09 Creatinine [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.5-1.1 mg/dL
http://loinc.org · 2160-0
S 1960-03-09 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 18 U/L
Reference <=33 U/L
http://loinc.org · 1742-6
S 1960-03-09 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20 U/L
Reference <=32 U/L
http://loinc.org · 1920-8
S 1960-03-18 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 1960-03-18 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 8 http://loinc.org · 70274-6
S 1960-04-20 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 1960-04-20 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 http://loinc.org · 70274-6
S 1960-06-15 Hemoglobin [Mass/volume] in Blood 12.8 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1960-06-15 Leukocytes [#/volume] in Blood by Automated count 5.9 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1960-06-15 Neutrophils [#/volume] in Blood by Automated count 3.4 10*3/uL
Reference 1.8-7.7 10*3/uL
http://loinc.org · 751-8
S 1960-06-15 Platelets [#/volume] in Blood by Automated count 240 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1960-06-15 Creatinine [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.5-1.1 mg/dL
http://loinc.org · 2160-0
S 1960-06-15 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1955)/1.73 sq M 87 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1960-06-15 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20 U/L
Reference <=33 U/L
http://loinc.org · 1742-6
S 1960-06-15 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference <=32 U/L
http://loinc.org · 1920-8
S 1960-06-15 Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 mg/dL
Reference <=1.2 mg/dL
http://loinc.org · 1975-2
S 1960-06-15 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1960-06-15 Magnesium [Mass/volume] in Serum or Plasma 2.1 mg/dL
Reference 1.7-2.4 mg/dL
http://loinc.org · 19123-9
S 1960-06-15 Calcium [Mass/volume] in Serum or Plasma 9.4 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1960-06-15 Cholesterol [Mass/volume] in Serum or Plasma 208 mg/dL (high)
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1960-06-15 Cholesterol in HDL [Mass/volume] in Serum or Plasma 62 mg/dL
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 1960-06-15 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 124 mg/dL (high)
Reference <=99 mg/dL
http://loinc.org · 13457-7
S 1960-06-15 Triglyceride [Mass/volume] in Serum or Plasma 110 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1960-06-15 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 22 ng/mL (low)
Reference 30-100 ng/mL
http://loinc.org · 62292-8
S 1960-06-15 Q-T interval corrected 418 ms
Reference Ribociclib is started only when QTcF is below 450 ms
http://loinc.org · 8636-3
S 1960-06-15 DXA Lumbar spine [T-score] Bone density -1.8 (low)
Reference >=-1
http://loinc.org · 38267-1
S 1960-06-15 DXA Femur [T-score] Bone density -1.3 (low)
Reference >=-1
http://loinc.org · 38263-0
S 1960-09-08 Hemoglobin [Mass/volume] in Blood 12.5 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1960-09-08 Leukocytes [#/volume] in Blood by Automated count 3.4 10*3/uL (low)
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1960-09-08 Neutrophils [#/volume] in Blood by Automated count 1.6 10*3/uL (low)
Reference 1.8-7.7 10*3/uL
http://loinc.org · 751-8
S 1960-09-08 Platelets [#/volume] in Blood by Automated count 192 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1960-09-08 Creatinine [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.5-1.1 mg/dL
http://loinc.org · 2160-0
S 1960-09-08 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 U/L
Reference <=33 U/L
http://loinc.org · 1742-6
S 1960-09-08 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 29 U/L
Reference <=32 U/L
http://loinc.org · 1920-8
S 1960-09-08 Bilirubin.total [Mass/volume] in Serum or Plasma 0.7 mg/dL
Reference <=1.2 mg/dL
http://loinc.org · 1975-2
S 1960-09-08 Potassium [Moles/volume] in Serum or Plasma 4.1 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1960-09-08 Magnesium [Mass/volume] in Serum or Plasma 2 mg/dL
Reference 1.7-2.4 mg/dL
http://loinc.org · 19123-9
S 1960-09-08 Calcium [Mass/volume] in Serum or Plasma 9.5 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1960-09-08 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 ng/mL
Reference 30-100 ng/mL
http://loinc.org · 62292-8
S 1960-09-08 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 1960-07-20 Leukocytes [#/volume] in Blood by Automated count 2.9 10*3/uL (low)
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1960-07-20 Neutrophils [#/volume] in Blood by Automated count 1.2 10*3/uL (low)
Reference 1.8-7.7 10*3/uL
http://loinc.org · 751-8
S 1960-07-20 Hemoglobin [Mass/volume] in Blood 12.2 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1960-07-20 Platelets [#/volume] in Blood by Automated count 168 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1960-10-13 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 1960-10-13 Total score [AUDIT-C] 1 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
1960-03-09Body height163 cm8302-2S
1960-03-09Body weight59.4 kg29463-7S
1960-03-09Body mass index (BMI) [Ratio]22.4 kg/m239156-5S
1960-03-09Systolic blood pressure124 mm[Hg]8480-6S
1960-03-09Diastolic blood pressure78 mm[Hg]8462-4S
1960-03-09Heart rate76 /min8867-4S
1960-03-09Respiratory rate14 /min9279-1S
1960-03-09Body temperature36.7 Cel8310-5S
1960-03-09Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1960-03-18Body height163 cm8302-2S
1960-03-18Body weight59 kg29463-7S
1960-03-18Body mass index (BMI) [Ratio]22.2 kg/m239156-5S
1960-03-18Systolic blood pressure130 mm[Hg]8480-6S
1960-03-18Diastolic blood pressure80 mm[Hg]8462-4S
1960-03-18Heart rate84 /min8867-4S
1960-03-18Respiratory rate16 /min9279-1S
1960-03-18Body temperature36.6 Cel8310-5S
1960-03-18Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1960-04-20Body height163 cm8302-2S
1960-04-20Body weight58.6 kg29463-7S
1960-04-20Body mass index (BMI) [Ratio]22.1 kg/m239156-5S
1960-04-20Systolic blood pressure122 mm[Hg]8480-6S
1960-04-20Diastolic blood pressure76 mm[Hg]8462-4S
1960-04-20Heart rate74 /min8867-4S
1960-04-20Respiratory rate14 /min9279-1S
1960-04-20Body temperature36.7 Cel8310-5S
1960-04-20Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1960-06-15Body height163 cm8302-2S
1960-06-15Body weight58.9 kg29463-7S
1960-06-15Body mass index (BMI) [Ratio]22.2 kg/m239156-5S
1960-06-15Systolic blood pressure120 mm[Hg]8480-6S
1960-06-15Diastolic blood pressure76 mm[Hg]8462-4S
1960-06-15Heart rate70 /min8867-4S
1960-06-15Respiratory rate14 /min9279-1S
1960-06-15Body temperature36.6 Cel8310-5S
1960-06-15Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1960-09-08Body height163 cm8302-2S
1960-09-08Body weight59.6 kg29463-7S
1960-09-08Body mass index (BMI) [Ratio]22.4 kg/m239156-5S
1960-09-08Systolic blood pressure118 mm[Hg]8480-6S
1960-09-08Diastolic blood pressure74 mm[Hg]8462-4S
1960-09-08Heart rate72 /min8867-4S
1960-09-08Respiratory rate14 /min9279-1S
1960-09-08Body temperature36.6 Cel8310-5S
1960-09-08Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1960-07-20Body height163 cm8302-2S
1960-07-20Body weight59.2 kg29463-7S
1960-07-20Body mass index (BMI) [Ratio]22.3 kg/m239156-5S
1960-07-20Systolic blood pressure118 mm[Hg]8480-6S
1960-07-20Diastolic blood pressure74 mm[Hg]8462-4S
1960-07-20Heart rate82 /min8867-4S
1960-07-20Respiratory rate16 /min9279-1S
1960-07-20Body temperature37.3 Cel8310-5S
1960-07-20Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1960-10-13Body height163 cm8302-2S
1960-10-13Body weight59.8 kg29463-7S
1960-10-13Body mass index (BMI) [Ratio]22.5 kg/m239156-5S
1960-10-13Systolic blood pressure116 mm[Hg]8480-6S
1960-10-13Diastolic blood pressure74 mm[Hg]8462-4S
1960-10-13Heart rate70 /min8867-4S
1960-10-13Respiratory rate14 /min9279-1S
1960-10-13Body temperature36.6 Cel8310-5S
1960-10-13Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Receive the biopsy result in person within ten days, explained in plain words, with a copy of the report1960-03-18completedTold the diagnosis in person nine days after presentation, with the pathology report in hand; teach-back confirmed her understanding
Make each treatment decision herself after hearing the options, benefits, and harms1960-04-20completedChose breast-conserving surgery and, after the pathology, radiation, letrozole, ribociclib, and zoledronic acid
Complete surgery and radiation, then start endocrine therapy, within four months of diagnosis1960-06-15completedLumpectomy at three weeks, radiation completed at ten weeks, letrozole and ribociclib started at thirteen weeks
Take adjuvant systemic therapy safely, with every safety check the drugs require done on schedule1960-12-07activeRibociclib started with QTcF 418 ms; blood counts and liver tests on schedule; the day-14 ECG was late, as recorded
Keep writing at least four mornings a week through treatment1960-12-07activeWriting most mornings, with radiation booked in the afternoons

Interventions

InterventionStatusGuideline
Diagnostic mammography and ultrasound of the left breast and axilla this week, then image-guided core biopsy with ER, PR, HER2, and Ki-67 testingcompletedGL-NCCN-BREAST-2025, GL-CMID-2026
Breast surgical oncology consultation once the biopsy result is available, to discuss surgical options and axillary staging with hercompletedGL-NCCN-BREAST-2025
Disclosure and shared decision-making: ask what she wants to know, give each result in person and in plain words with a written copy, check understanding by teach-back, and make every decision with her; share her health information only with the people she namescompletedGL-AMA-2.1.3, GL-ASCO-COMM-2017
Test of cure for Helicobacter pylori by urea breath test at least four weeks after antibiotics and two weeks after stopping omeprazolecompletedGL-ACG-HP-2024
Knee osteoarthritis: walking and strengthening exercise, acetaminophen as needed, no nonsteroidal anti-inflammatory drugs after her ulcercompletedGL-ACR-OA-2019
Germline multigene panel testing with genetic counseling before surgery, as recommended for breast cancer diagnosed at 65 or youngercompletedGL-ASCO-SSO-GERM-2024, GL-NCCN-BREAST-2025
Left breast-conserving surgery (lumpectomy) with sentinel lymph node biopsy, her choice after mastectomy was also explained; no axillary dissection if one or two sentinel nodes are involved and she has whole-breast radiationcompletedGL-NCCN-BREAST-2025, GL-ASCO-AXILLA-2021
Hypofractionated whole-breast and regional nodal radiation with a tumor-bed boost by the radiation oncology team, booked in the afternoons so she can write in the morningscompletedGL-NCCN-BREAST-2025
Letrozole 2.5 mg daily for at least five years with ribociclib 400 mg on days 1 to 21 of each 28-day cycle for three years, chosen by her; no chemotherapy with a recurrence score of 17; ECG before starting and about day 14, blood counts and liver tests every two weeks for two cycles and then at the start of the next four cycles, and electrolytes at the start of the first six cycles; avoid drugs that prolong the QT intervalcompletedGL-NCCN-BREAST-2025, GL-ASCO-CDK46-2024, GL-FDA-RIBOCICLIB-2026, GL-ASCO-ENDO-2019
Bone health: baseline DXA, dental check, then zoledronic acid 4 mg every six months for three years; vitamin D and calcium from food; weight-bearing exercise; DXA every two yearscompletedGL-ASCO-BMA-2022, GL-CMID-2026
Survivorship care: history and examination every 3 to 6 months, a mammogram 6 to 12 months after radiation and then yearly, no routine tumor markers or body imaging; lymphedema checks, joint-pain and hot-flash review, distress screening, and a written survivorship care plancompletedGL-CMID-2026, GL-ACS-ASCO-SURV-2016, GL-ASCO-FU-2013

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Rachel Carson National Park Service government
SRC-0002 About Rachel Carson Rachel Carson Council biography
SRC-0003 Rachel Carson (scientific biography) Science History Institute biography
SRC-0004 Carson, Rachel (1907–1964). Women in World History: A Biographical Encyclopedia Encyclopedia.com (Gale) biography
SRC-0005 Stevens A. Review of Rachel Carson: Witness for Nature, by Linda Lear The Trumpeter (Athabasca University) scholarly
SRC-0006 Call for a Cure Seattle Weekly other
SRC-0007 Lear L, ed. Letter to Dr. George Crile, Jr., with the editor's headnote. In: Lost Woods: The Discovered Writing of Rachel Carson (Beacon Press, 1998) Online transcription (publicism.info) primary
SRC-0008 Griswold E. How 'Silent Spring' Ignited the Environmental Movement. New York Times Magazine, September 21, 2012 (reprint) The New York Times (reprint PDF) other
SRC-0009 Rachel Carson's Statement before Congress, 1963 Rachel Carson Council primary
SRC-0010 Rachel Carson (1907–1964). Maryland Women's Hall of Fame Maryland State Archives government
SRC-0011 McCauley M. Rachel Carson, Author of Silent Spring Literary Ladies Guide biography
SRC-0012 Oken D. What to tell cancer patients. A study of medical attitudes. JAMA 1961;175:1120-8. PMID 13730593 JAMA (PubMed record) scholarly
SRC-0013 Novack DH, et al. Changes in physicians' attitudes toward telling the cancer patient. JAMA 1979;241(9):897-900. PMID 762865 JAMA (PubMed abstract) scholarly
SRC-0014 Burstein HJ. Fifty years of systemic therapy for breast cancer: from one size fits all to tailored therapy. Am Soc Clin Oncol Educ Book 2014:e1-3. PMID 24857085 American Society of Clinical Oncology (PubMed abstract) scholarly
SRC-0015 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check omission of axillary dissection with two positive sentinel nodes, regional nodal radiation, omission of chemotherapy at recurrence score 17, the adjuvant ribociclib choice and its monitoring, and adjuvant zoledronic acid.
provenance reviewnot_startedHer illness is documented from the Science History Institute, the National Park Service, the Rachel Carson Council, a Gale reference biography, a journal review of the standard biography, her biographer's headnote to a letter, a news feature, and a magazine article; the 1950 operation rests on one popular biography and is graded probable. The surgeon is not named; no relative or friend is quoted.
safe messaging reviewnot_startedNo behavioral-health diagnosis; mild distress at diagnosis is screened and supported; her documented wish for privacy is respected; death recorded without detail.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.